Sunday, August 1, 2021

Opdivo plus Cabometyx approved in the EU for advanced renal cancer




The European Commission (EC) has authorised Bristol Myers Squibb’s (BMS) Opdivo plus Ipsen’s Cabometyx as a first-line treatment for advanced renal cell carcinoma (aRCC).

The EU approval is based on results from the Phase III CheckMate-9ER trial, which evaluated Opdivo (nivolumab) in combination with Cabometyx (cabozantinib) in previously untreated advanced or metastatic renal cell carcinoma patients.

In this study, Opdivo plus Cabometyx doubled progression-free survival compared to patients receiving Pfizer’s tyrosine kinase inhibitor (TKI) Sutent (sunitinib) alone – 16.6 months versus 8.3 months respectively.

The Opdivo and Cabometyx combination also reduced the risk of death by 40% compared to the TKI inhibitor, and also demonstrated a superior objective response rate (ORR) – twice as many patients responded to BMS/Ipsen’s drugs compared to Sutent.

“Today’s EC approval for the use of Cabometyx in combination with Opdivo provides an important new first-line treatment option for patients living with advanced renal cell carcinoma,” said Howard Mayer, executive vice president and head of research and development, Ipsen.

“We look forward to collaborating with a broad range of European stakeholders to bring this unique combination to eligible patients living with advanced renal cell carcinoma,” he added.



Source link

Stay Connected

1,605FansLike
11,000FollowersFollow
342FollowersFollow
775FollowersFollow

Latest Articles

Need to create vigilance and awareness on zoonotic diseases: India’s Health Minister

The COVID-19 pandemic has highlighted the need of creating vigilance and awareness on zoonotic diseases, informed Union Health Minister Mansukh Mandaviya while virtually inaugurating...

Covid’s second wave proves lethal for pregnant women

At SVP Hospital in Ahmedabad – one of the major Covid-19 hospitals of the city – 148 pregnant women with Covid-19 infection were admitted...

7 Tips to Keep Your Gut Healthy

This is common to say health (and illness) starts in your gut. If you have poor gut health, you’ll experience anything from wrinkled skin, to...

SII making first batch of Covovax: Poonawalla

The first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India's Pune facility, SII...

Sputnik V is safest among all Covid-19 vaccines, no deaths recorded: Buenos Aires study

A study by the Buenos Aires Ministry of Health to monitor the safety of the Sputnik V vaccine against Covid-19 confirmed on Thursday that...